Dendritic Cells in Antitumor Immune Responses II. Dendritic Cells Grown from Bone Marrow Precursors, but Not Mature DC from Tumor-Bearing Mice, Are Effective Antigen Carriers in the Therapy of Established Tumors

By Gabrilovich D.I.   Nadaf S.   Corak J.   Berzofsky J.A.   Carbone D.P.  

Cellular Immunology, Vol. 170, Iss. 1, 1996-05 ,pp. : 111-119

Academic Press

Access to resources Recommend Favorite

Presentation of MUC1 Tumor Antigen by Class I MHC and CTL Function Correlate with the Glycosylation State of the Protein Taken Up by Dendritic Cells

By Hiltbold E.M.   Alter M.D.   Ciborowski P.   Finn O.J.  

Cellular Immunology, Vol. 194, Iss. 2, 1999-06 ,pp. : 143-149

Academic Press

Access to resources Recommend Favorite

Antigen Presentation by B7- Nonprofessional APC Does Not Prevent Responses to Solid Tumor Cells

By Salvadori S.   Moran T.   Zier K.  

Cellular Immunology, Vol. 183, Iss. 1, 1998-01 ,pp. : 52-59

Academic Press

Access to resources Recommend Favorite

IL-15 Mediates Anti-tumor Effects after Cyclophosphamide Injection of Tumor-Bearing Mice and Enhances Adoptive Immunotherapy: The Potential Role of NK Cell Subpopulations

By Evans R.   Fuller J.A.   Christianson G.   Krupke D.M.   Troutt A.B.  

Cellular Immunology, Vol. 179, Iss. 1, 1997-07 ,pp. : 66-73

Academic Press

Access to resources Recommend Favorite

Enhanced Immune Response to the Melanoma Antigen gp100 Using Recombinant Adenovirus-Transduced Dendritic Cells

By Wan Y.   Emtage P.   Zhu Q.   Foley R.   Pilon A.   Roberts B.   Gauldie J.  

Cellular Immunology, Vol. 198, Iss. 2, 1999-12 ,pp. : 131-138

Academic Press

Access to resources Recommend Favorite